Favorable outcomes with alemtuzumab-conditioned unrelated donor stem cell transplantation in adults with high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in first complete remission

Background Approximately 40% of adults with Philadelphia chromosome-negative acute lymphoblastic leukemia achieve long-term survival following unrelated donor hematopoietic stem cell transplantation in first complete remission but severe graft-versus-host disease remains a problem affecting survival...

Descripció completa

Dades bibliogràfiques

Autors principals:	Bella Patel, Keiren E. Kirkland, Richard Szydlo, Rachel M. Pearce, Richard E. Clark, Charles Craddock, Effie Liakopoulou, Adele K. Fielding, Stephen Mackinnon, Eduardo Olavarria, Mike N. Potter, Nigel H. Russell, Bronwen E. Shaw, Gordon Cook, Anthony H. Goldstone, David I. Marks
Format:	Artigo
Idioma:	Inglês
Publicat:	Ferrata Storti Foundation 2009-10-01
Col·lecció:	Haematologica
Accés en línia:	https://haematologica.org/article/view/5376
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!